Advertisement

Pharmacological models of generalized absence seizures in rodents

  • O. Carter SneadIII
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 35)

Summary

A number of animal models of generalized absence seizures in rodents are described. These include absence seizures induced by γ-hydroxybutyrate (GHB), low dose pentylenetetrazole, penicillin, THIP and AY-9944. All of these models share behavioral and EEG similarity to human absence seizures and show pharmacologic specificity for antiabsence drugs such as ethosuximide and trimethadione. Moreover, the absence seizures induced by these agents are exacerbated by GABAergic agonists, a property unique to experimental absence seizures. These models are predictable, reproducible, and easy to standardize. They are useful both in studying mechanisms of pathogenesis of absence seizures as well as in screening for antiabsence activity of potential antiepileptic drugs.

Keywords

Absence Seizure Wave Discharge Gaba Agonist Potential Antiepileptic Drug GABAergic Agonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Avoli M (1980) Electroencephalographic and pathophysiologic features of rat par-enteral penicillin epilepsy. Exp Neurol 69: 373–382PubMedCrossRefGoogle Scholar
  2. Bearden LJ, Snead OC, Healy CT, Pegram GV (1980) Antagonism of gamma hydroxybutyrate-induced frequency shifts in the cortical EEG of rats by dipropylacetate. Electroencephalogr Clin Neurophysiol 49: 181–183PubMedCrossRefGoogle Scholar
  3. Berkovic SF, Andermann F, Andermann E, Gloor P (1987) Concepts of absence epilepsies: discrete syndromes or biological continuum? Neurology 37: 993–1000PubMedGoogle Scholar
  4. Black JA, Golden GT, Fariello RG (1980) Ketamine activation of experimental corticoreticular epilepsy. Neurology 30: 315–318PubMedGoogle Scholar
  5. Bo GP, Fonzari M, Scotto PA, Benassi E (1984) Parenteral penicillin epilepsy: tolerance to subsequent treatments. Exp Neurol 85: 229–232PubMedCrossRefGoogle Scholar
  6. Browning RA, Nelson DK (1986) Modification of electroshock and pentylenetetrazol seizure patterns in rats after pericollicular transections. Exp Neurol 93: 546–556PubMedCrossRefGoogle Scholar
  7. Cenedella RJ (1980) Concentration dependent effects of AY-9944 and U18–666A on sterol synthesis in brain. Variable sensitivities of metabolic steps. Biochem Pharmacol 29: 2753–2760CrossRefGoogle Scholar
  8. Depaulis A, Bourguignon J, Marescaux C, Vergnes M, Schmitt M, Micheletti G, Warter JM (1988) Effect of y-hydroxybutyrate and y-butyrolactone derivatives on spontaneous generalized non-convulsive seizures in the rat. Neuropharmacology 27: 6863–689CrossRefGoogle Scholar
  9. Depaulis A, Vergnes M, Marescaux C, Lannes B, Warter JM (1988) Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike and wave discharges in the rat. Brain Res 448: 20–29PubMedCrossRefGoogle Scholar
  10. Depaulis A, Snead OC, Marescaux C, Vergnes M (1989) Suppressive effects of intranigral injection of mucsimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 1498: 64–72Google Scholar
  11. Depaulis A, Liu Z, Vergnes M, Marescaux C, Micheletti G, Warter JM (1990) Suppression of spontaneous generalized non-convulsive seizures in the rat byGoogle Scholar
  12. microinjection of GABA antagonists into the superior colliculus. Epilepsy Res 5: 192–198Google Scholar
  13. Dvornik D, Hill P (1968) Effects of long term administration of AY-9944, an inhibitor of 7-dehydrocholesterol delta7-reductase on serum and tissue lipids in the rat. J Lipid Res 9: 587–592PubMedGoogle Scholar
  14. Fariello RG (1979) Action of inhibitory amino acids on acute epileptic foci: an electrographic study. Exp Neurol 66: 55–63PubMedCrossRefGoogle Scholar
  15. Fariello RG, Golden GT (1987) The THIP induced model of bilateral synchronous spike and wave in rodents. Neuropharmacology 26: 161–165PubMedCrossRefGoogle Scholar
  16. Fisher RS, Prince DA (1977) Spike-wave rhythms in cat cortex induced by parenteral penicillin. II. Cellular features. Electroencephalogr Clin Neurophysiol 42: 625–639PubMedCrossRefGoogle Scholar
  17. Fromm GH, Kohli CM (1972) The role of inhibitory pathways in petit mal epilepsy.Neurology 22: 101–220Google Scholar
  18. Gloor P (1984) Electrophysiology of generalized epilepsy. In: Schwartzkroin PA, Wheal (eds) Electrophysiology of epilepsy. Academic Press, New York, pp 107–136Google Scholar
  19. Gloor P, Testa G (1974) Generalized penicillin epilepsy in the cat: effects of intracarotid and intravertebral pentylenetetrazol and amobarbital injections. Electroencephalogr Clin Neurophysiol 36: 499–515PubMedCrossRefGoogle Scholar
  20. Gloor P, Fariello RG (1988) Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurol Sci 11: 63–68CrossRefGoogle Scholar
  21. Godschalk M, Dzoljic MR, Bonta IL (1976) Antagonism of gamma-hydroxybutyrateinduced hypersynchronization in the ECoG of rat by anti-petit mal drugs. Neurosci Lett 3: 1173–1178CrossRefGoogle Scholar
  22. Godschalk M, Dzoljic MR, Bonta IL (1977) Slow wave sleep and a state resembling absence epilepsy induced in the rat by y-hydroxybutyrate. Eur J Pharmacol 44: 105–111PubMedCrossRefGoogle Scholar
  23. Guberman A, Gloor P, Sherwin AL (1975) Response of generalized penicillin epilepsy in the cat to ethosuximide and diphenylhydantoin. Neurology 25: 758–764Google Scholar
  24. Kent AP, Webster RA (1986) The role of GABA and excitatory amino acids in the development of the leptazol-induced epileptogenic EEG. Neuropharmcology 25: 1023–1030CrossRefGoogle Scholar
  25. Kostopoulos G (1986) Neuronal sensitivity to GABA and glutamate in generalized epilepsy with spike and wave discharges. Exp Neurol 92: 20–36PubMedCrossRefGoogle Scholar
  26. Krall RL, Penry JK, Whiite BG, Kupferberg JH, Swinyard EA (1978) Antiepileptic drug development. II. Anticonvulsant drug screening. Epilepsia 22: 107–122Google Scholar
  27. Liu Z, Snead OC, Vergnes M, Depaulis A, Marescaux C (1991) Intrathalamic injections of gamma-hydroxybutyric acid increase genetic absence seizures in rats. Neurosci Lett 125: 19–21PubMedCrossRefGoogle Scholar
  28. Lockman LA (1989) Absence, myoclonic and atonic seizures. Pediatr Clin North Am 36: 331–343PubMedGoogle Scholar
  29. Loscher W (1982) Comparative assay of anticonvulsant and toxic potencies of sixteen GABAmimetic drugs. Neuropharmacology 21: 803–810PubMedCrossRefGoogle Scholar
  30. Mares P, Maresova D, Trojan S, Fischer J (1982) Ontogenetic development of rhythmic thalamocortical phenomena in the rat. Brain Res Bull 8: 765–769PubMedCrossRefGoogle Scholar
  31. Marescaux C, Micheletti G, Vergnes M, Depaulis A, Rumbach L, Warter JM (1984) A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazole-induced seizures. Epilepsia 25: 326–331PubMedCrossRefGoogle Scholar
  32. McQueen JK, Woodbury DM (1975) Attempts to produce spike-wave complexes in the electrocorticogram of the rat. Epilepsia 16: 295–299PubMedCrossRefGoogle Scholar
  33. Mirski MA, Ferendelli JA (1986) Anterior thalamic mediation of generalized pentylenetetrazol seizures. Brain Res 399: 212–223PubMedCrossRefGoogle Scholar
  34. Mirski MA, McKeon AC, Ferendelli JA (1986) Anterior thalamus and substantia nigra: two distinct structures mediating experimental generalized seizures. Brain Res 397: 377–380PubMedCrossRefGoogle Scholar
  35. Mysloblodsky MS, Ackerman RF, Engel J (1979) Effects of y-acetylenic GABA and y-vinyl GABA on metrazol-activated and kindled seizures. Pharmacol Biochem Behav 11: 265–271CrossRefGoogle Scholar
  36. Peeters BWMM, Van Rijn CM, Vossen JMH, Coenen AML (1989) Effects of GABAergic agents on spontaneous non-convulsive epilepsy, EEG and behavior, in the WAG/RIJ inbred strain of rats. Life Sci 45: 1171–1176PubMedCrossRefGoogle Scholar
  37. Penry JK, Porter RJ, Dreifuss FE (1975) Simultaneous recording of absence seizures with videotape and electroencephalography. A study of 374 seizures in 48 patients. Brain 98: 427–440PubMedCrossRefGoogle Scholar
  38. Quesney LF (1984) Pathophysiology of generalized photosensitive epilepsy in the cat. Epilepsia 25: 61–69PubMedCrossRefGoogle Scholar
  39. Roseman E (1961) Dilantin toxicity: a clinical and EEG study. Neurology 11: 912–917PubMedGoogle Scholar
  40. Roth RH, Giarman NJ (1969) Conversion in vivo of y-aminobutyric acid to yhydroxybutyrate in the rat. Biochem Pharmacol 18: 247–250PubMedCrossRefGoogle Scholar
  41. Smith KA, Bierkamper GG (1990) Paradoxical role of GABA in a chronic model of petit mal (absence)-like epilepsy in the rat. Eur J Pharmacol 176: 45–55PubMedCrossRefGoogle Scholar
  42. Snead OC (1978) Gamma-hydroxybutyrate in the monkey. I. Electroencephalographic, behavioral, and pharmacokinetic studies. Neurology 28: 636–642PubMedGoogle Scholar
  43. Snead OC (1978) Gamma-hydroxybutyrate in the monkey. II. Effect of chronic oral anticonvulsant drugs. Neurology 28: 643–648PubMedGoogle Scholar
  44. Snead OC (1978) Gamma-hydroxybutyrate in the monkey. III. Effect of intravenous anticonvulsant drugs. Neurology 28: 1173–1182PubMedGoogle Scholar
  45. Snead OC (1983) On the sacred disease: the neurochemistry of epilepsy. Int Rev Neurobiol 24: 94–180Google Scholar
  46. Snead OC (1984a) Gamma-hydroxybutyric acid, y-aminobutyric acid and petit mal epilepsy. In: Fariello RG, Morselli PL, Lloyd KG, Quesney LF, Engel J (eds) Neurotransmitters, seizures, and epilepsy, II. Raven Press, New York, pp 37–47Google Scholar
  47. Snead OC (1984b) Ontogency of y-hydroxybutyric acid. II. Electroencephalographic effects. Dev Brain Res 15: 89–96CrossRefGoogle Scholar
  48. Snead OC (1988) γ-hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models. Epilepsia 29: 361–368Google Scholar
  49. Snead OC (1990) The ontogeny of muscimol enhancement of the y-hydroxybutyrate model of generalized absence seizures. Epilepsia 31: 363–368PubMedCrossRefGoogle Scholar
  50. Snead OC (1991) The y-hydroxybutyrate model of absence seizures: correlation of regional brain levels of y-hydroxybutyric acid and y-butyrolactone with spike wave discharges. Neuropharmacology 30: 161–167PubMedCrossRefGoogle Scholar
  51. Snead OC, Hosey LC (1985) Exacerbation of seizures in children by carbamazepine. N Engl J Med 313: 916–921PubMedCrossRefGoogle Scholar
  52. Snead OC, Yu RK, Huttenlocher PR (1976) Gamma-hydroxybutyrate: correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioral effects. Neurology 26: 51–56PubMedGoogle Scholar
  53. Snead OC, Bearden LJ, Healy CT, Pegram V (1980) Effect of acute and chronic anticonvulsant administration on endogenous y-hydroxybutyrate in rat brain. Neuropharmacology 19: 47–52PubMedCrossRefGoogle Scholar
  54. Steriade M, Llinas RR (1988) The functional state of the thalamus and the associated neuronal interplay. Physiol Rev 68: 649–742PubMedGoogle Scholar
  55. Swinyard EA (1969) Laboratory evaluation of antiepileptic drugs. Epilepsia 10: 107–119PubMedCrossRefGoogle Scholar
  56. Taylor-Courval D, Gloor P (1984) Behavioral alterations associated with generalized spike and wave discharges in the EEG of the cat. Exp Neurol 83: 167–186PubMedCrossRefGoogle Scholar
  57. Unnerstall JR, Pizzi WJ (1981) Muscimol and y-hydroxybutyrate: similar interactions with convulsant agents. Life Sci 29: 337–344PubMedCrossRefGoogle Scholar
  58. Van der Linden GJ, Meinardi H, Meijer SWA, Bossi L, Gomeni CA (1981) A double blind crossover trial with progabide (SL76002) against placebo in patients with secondary generalized epilepsy. In: Dam M, Gram L, Penry JK (eds) Advances in Epileptology: XIIth Epilepsy International Symposium. Raven Press, New York, pp 141–144Google Scholar
  59. Vayer P, Mandel P, Maitre M (1987) y-Hydroxybutyrate, a possible neurotransmitter. Life Sci 41: 1547–1557Google Scholar
  60. Vergnes M, Marescaux C, Micheletti G, Depaulis A, Rumbach L, Warter JM (1984) Enhancement of spike and wave discharges by GABA-mimetic drugs in rat with spontaneous petit mal-like epilepsy. Neurosci Lett 44: 91–94PubMedCrossRefGoogle Scholar
  61. Vergnes M, Marescaux C, Micheletti G, Rumbach L, Waiter JM (1985) Blockade of antiabsence activity of sodium valproate by THIP in rats with petit mal-like seizures. J Neural Transm 63: 133–141PubMedCrossRefGoogle Scholar
  62. Vergnes M, Marescaux C, Depaulis A, Micheletti G, Warter JM (1987) Spontaneous spike and wave discharges in thalamus and cortex in a rat model of genetic petit mal like seizures. Exp Neurol 96: 127–136PubMedCrossRefGoogle Scholar
  63. Vergnes M, Marescaux C, Depaulis A, Micheletti G, Warter JM (1990) The spontaneous spike and wave discharges in wistar rats: a model of genetic generalized non-convulsive epilepsy. In: Avoli M, Gloor P, Kostopoulous G, Naquet R (eds) Neurobiological approaches. Birkhäuser, New York, pp 238–253Google Scholar
  64. Williams D (1953) A study of thalamic and cortical rhtythms in petit mal. Brain 76: 50–69PubMedCrossRefGoogle Scholar
  65. Zouhar A, Mares P, Brozek G (1980) Electrocorticographic activity elicited by metrazol during ontogenesis in rats. Arch Int Pharmacodyn Ther 248: 280–288PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • O. Carter SneadIII
    • 1
    • 2
  1. 1.Division of Neurology, Children’s Hospital, Los Angeles, and Department of NeurologyUniversity of Southern California School of MedicineLos AngelesUSA
  2. 2.Division of NeurologyChildren’s Hospital, Los AngelesLos AngelesUSA

Personalised recommendations